<!DOCTYPE html>
<html lang="en">
  <head>
    <meta http-equiv="X-UA-Compatible" content="IE=Edge">
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width,initial-scale=1">
    <meta name="theme-color" content="#000000">
    <link rel="stylesheet" href="https://use.typekit.net/xkz5olp.css">
    <link rel="preconnect" href="https://www.spectator.co.uk">
    <link rel="preconnect" href="d3jumesoomqjvn.cloudfront.net">
    <meta property="twitter:card" content="summary_large_image">
    <meta property="twitter:site" content="@spectator">
    <meta name="msapplication-TileColor" content="#2b5797">
    <meta name="theme-color" content="#d2091e">
    <link rel="apple-touch-icon" sizes="57x57" href="/apple-touch-icon-57x57.png">
    <link rel="apple-touch-icon" sizes="60x60" href="/apple-touch-icon-60x60.png">
    <link rel="apple-touch-icon" sizes="72x72" href="/apple-touch-icon-72x72.png">
    <link rel="apple-touch-icon" sizes="76x76" href="/apple-touch-icon-76x76.png">
    <link rel="apple-touch-icon" sizes="114x114" href="/apple-touch-icon-114x114.png">
    <link rel="apple-touch-icon" sizes="120x120" href="/apple-touch-icon-120x120.png">
    <link rel="apple-touch-icon" sizes="144x144" href="/apple-touch-icon-144x144.png">
    <link rel="apple-touch-icon" sizes="152x152" href="/apple-touch-icon-152x152.png">
    <link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon-180x180.png">
    <link rel="icon" type="image/png" href="/favicon-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/android-chrome-192x192.png" sizes="192x192">
    <link rel="icon" type="image/png" href="/favicon-96x96.png" sizes="96x96">
    <link rel="icon" type="image/png" href="/favicon-16x16.png" sizes="16x16">
    <link rel="manifest" href="/manifest.json">
    <meta name="msapplication-TileImage" content="/mstile-144x144.png">
    
    <link href="/main.css" rel="stylesheet">
    

    <!-- Start Iubenda -->
    <!-- __spc is used to indicate if Iubenda has already given privacy consent to us by the time our application has loaded. -->
    <!-- __spcpriv.update() is used to notify the application of whether or not the user has consented. This gets replaced with a hook into
         the application so we get an immediate notification if the user consents after the application has loaded. -->
    <script type="text/javascript">
      window.__spc = true
      window.__spcpriv = {
        update: change => (window.__spc = change)
      }
    </script>

    

    <script type="text/javascript">
      var _iub = _iub || []
      _iub.csConfiguration = {
        cookiePolicyInOtherWindow: true,
        countryDetection: true,
        enableCMP: true,
        gdprAppliesGlobally: false,
        lang: 'en',
        siteId: 1724020,
        askConsentIfCMPNotFound: true,
        isTCFConsentGlobal: true,
        cookiePolicyId: 84586425,
        perPurposeConsent: true,
        cookiePolicyUrl: '/privacy-policy',
        callback: {
          onConsentGiven: () => window.__spcpriv.update(true),
          onPreferenceNotNeeded: () => window.__spcpriv.update(true)
        },
        banner: {
          closeButtonDisplay: false,
          position: 'float-bottom-right',
          textColor: 'black',
          backgroundColor: 'white',
          acceptButtonDisplay: true,
          acceptButtonColor: '#d2091e',
          acceptButtonCaptionColor: 'white',
          customizeButtonDisplay: true,
          customizeButtonCaptionColor: 'white',
          customizeButtonColor: 'gray',
          content:
            '<p>We use cookies to help our website work, to understand how it is used and to choose the adverts you are shown.</p>  <p>By clicking "Accept" or interacting with the web site you agree to us doing so. You can read more in our <a href="/privacy-policy">privacy policy</a>.</p'
        }
      }
    </script>
    <script type="text/javascript">
      var _iub = _iub || {}
      _iub.cons_instructions = _iub.cons_instructions || []
      _iub.cons_instructions.push(['init', { api_key: 'K4eFvrmUBb9lrl3i2PUZ4kvkPy6L2ZR4' }])
    </script>
    <script type="text/javascript" src="//cdn.iubenda.com/cons/iubenda_cons.js" async></script>
    <script type="text/javascript" src="//cdn.iubenda.com/cs/tcf/stub.js"></script>
    <script type="text/javascript" src="//cdn.iubenda.com/cs/iubenda_cs.js" charset="UTF-8" async></script>
    

    <!-- End Iubenda -->
  <title>The contenders – and challenges – in the race to cure Covid | The Spectator</title>
<meta name="description" content="There are reasons to be optimistic about the therapies being tested">
<meta property="og:description" content="There are reasons to be optimistic about the therapies being tested">
<meta property="og:type" content="article">
<meta property="og:title" content="The contenders – and challenges – in the race to cure Covid | The Spectator">
<meta property="og:url" content="https://www.spectator.co.uk/article/the-contenders-and-challenges-in-the-race-to-cure-covid">
<meta property="twitter:image" content="https://images.contentstack.io/v3/assets/bltf04078f3cf7a9c30/blt98c910a52989f814/5e9ed458c492412a1bbc190e/chemical-weapons.jpg?format=jpg&width=4096&height=2048&fit=crop&disable=upscale&quality=80">
<meta property="og:image" content="https://images.contentstack.io/v3/assets/bltf04078f3cf7a9c30/blt98c910a52989f814/5e9ed458c492412a1bbc190e/chemical-weapons.jpg">
<link rel="canonical" href="https://www.spectator.co.uk/article/the-contenders-and-challenges-in-the-race-to-cure-covid">
<meta name="author" content="Matt Ridley">
<meta name="section" content="Features">
<meta property="article:author" content="Matt Ridley">
<link rel="amphtml" href="https://www.spectator.co.uk/article/the-contenders-and-challenges-in-the-race-to-cure-covid/amp">
    </head>

  <body>
    <script type="text/javascript">
    window.__spectator_state_v1_article = JSON.parse(decodeURIComponent("%7B%22article%22%3A%7B%22uid%22%3A%22blt2bed63306951402f%22%2C%22type%22%3A%22article%22%2C%22title%22%3A%22The%20contenders%20%E2%80%93%20and%20challenges%20%E2%80%93%20in%20the%20race%20to%20cure%20Covid%22%2C%22url%22%3A%22%2Farticle%2Fthe-contenders-and-challenges-in-the-race-to-cure-covid%22%2C%22wpid%22%3A%22%22%2C%22date%22%3A%222020-04-23T08%3A00%3A00.000Z%22%2C%22hero_image%22%3A%22https%3A%2F%2Fimages.contentstack.io%2Fv3%2Fassets%2Fbltf04078f3cf7a9c30%2Fblt98c910a52989f814%2F5e9ed458c492412a1bbc190e%2Fchemical-weapons.jpg%22%2C%22hero_video%22%3A%22%22%2C%22hero_image_alt%22%3A%22The%20contenders%20%E2%80%93%20and%20challenges%20%E2%80%93%20in%20the%20race%20to%20cure%20Covid%22%2C%22byline%22%3A%22There%20are%20reasons%20to%20be%20optimistic%20about%20the%20therapies%20being%20tested%22%2C%22text_body%22%3A%22%3Cp%3EA%20striking%20feature%20of%20Covid-19%20is%20how%20medieval%20our%20response%20has%20had%20to%20be.%20Quarantine%20was%20the%20way%20people%20fought%20plagues%20in%20the%20distant%20past.%20We%20know%20by%20now%20that%20it%20will%20take%20many%20months%20to%20get%20a%20vaccine%2C%20whose%20job%20is%20to%20prevent%20you%20getting%20the%20disease.%20But%20what%20about%20a%20cure%20once%20you%20have%20caught%20it%3A%20why%20is%20there%20no%20pill%20to%20take%3F%20The%20truth%20is%20that%2C%20advanced%20as%20medical%20science%20is%2C%20we%20are%20mostly%20defenceless%20against%20viruses.%20There%20is%20no%20antiviral%20therapy%20to%20compare%20with%20antibiotics%20for%20treating%20bacteria.%3C%2Fp%3E%5Cn%3Cp%3EArguably%2C%20virology%20in%202020%20is%20where%20bacteriology%20was%20in%20the%201920s.%20At%20the%20time%2C%20most%20of%20the%20experts%20in%20that%20field%20%E2%80%94%20including%20Alexander%20Fleming%20and%20his%20mentor%2C%20the%20formidable%20Sir%20Almroth%20Wright%20(nicknamed%20Sir%20Always%20Wrong%20by%20his%20foes)%20%E2%80%94%20thought%20a%20chemical%20therapy%20that%20killed%20bacteria%20without%20harming%20the%20patient%20was%20a%20wild%20goose%20chase.%20Instead%2C%20they%20argued%2C%20theway%20to%20fight%20bacteria%20was%20to%20encourage%20the%20body%E2%80%99s%20immune%20system.%20%E2%80%98Stimulate%20the%20phagocytes!%E2%80%99%20was%20the%20cry%20of%20Wright%E2%80%99s%20semi-fictional%20avatar%20Sir%20Colenso%20Ridgeon%20in%20George%20Bernard%20Shaw%E2%80%99s%20play%20%3Cem%3EThe%20Doctor%E2%80%99s%20Dilemma%3C%2Fem%3E%20(referring%20to%20white%20blood%20cells).%20Vaccines%20should%20be%20used%20to%20treat%20as%20well%20as%20prevent%20infections%2C%20thought%20Wright%20and%20Fleming.%20Fleming%20then%20turned%20this%20theory%20upside%20down%20with%20his%20discovery%20of%20penicillin%20in%201928.%3C%2Fp%3E%5Cn%3Cp%3EThere%20are%20two%20reasons%20for%20this%20failure%20to%20have%20anything%20on%20the%20shelf%20that%20can%20be%20used%20to%20treat%20viruses%3A%20one%20biological%2C%20the%20other%20economic.%20The%20biological%20problem%2C%20as%20Amesh%20Adalja%20of%20Johns%20Hopkins%20University%20argued%20in%20a%20prescient%20call%20to%20arms%20just%20before%20the%20pandemic%20struck%2C%20is%20that%20viruses%20do%20not%20have%20their%20own%20biochemistry%2C%20because%20they%20borrow%20ours.%3C%2Fp%3E%5Cn%3Cp%3ESo%20unlike%2C%20say%2C%20tuberculosis%2C%20there%20is%20not%20much%20to%20attack.%20As%20any%20doctor%20will%20tell%20you%2C%20antibiotics%20are%20no%20use%20in%20fighting%20a%20virus.%20They%20interfere%20with%20machinery%20found%20only%20in%20bacteria%2C%20but%20there%20is%20no%20equivalent%20machinery%20in%20viruses%20%E2%80%94%20which%20are%20just%20a%20bunch%20of%20genes%20(15%20of%20them%20in%20the%20case%20of%20Sars-CoV-2)%20that%20borrow%20our%20body%E2%80%99s%20machinery%20to%20replicate%20themselves.%3C%2Fp%3E%5Cn%3Cp%3EThe%20problem%20is%20that%20viruses%20differ%20from%20each%20other%2C%20so%20treatments%20that%20work%20for%20one%20seldom%20work%20for%20another.%20The%20drugs%20that%20work%20against%20HIV-1%2C%20the%20main%20cause%20of%20Aids%2C%20sometimes%20do%20not%20even%20work%20against%20HIV-2%2Ca%20milder%20version%20of%20the%20virus.%20Those%20that%20work%20against%20herpes%20don%E2%80%99t%20kill%20the%20very%20similar%20cytomegalovirus.%20One%20influenza%20drug%20works%20only%20against%20influenza%20A%20and%20not%20B.%20One%20antiviral%20kills%20just%20one%20genotype%20of%20hepatitis%20C.%20It%20is%20no%20coincidence%20that%20the%20antiviral%20treatments%20capable%20of%20attacking%20more%20kinds%20of%20virus%2C%20such%20as%20ribavirin%2C%20are%20also%20the%20most%20toxic%20to%20the%20patient%2C%20because%20they%20tend%20to%20attack%20the%20machinery%20of%20the%20host%20as%20well.%3C%2Fp%3E%5Cn%3Cp%3EThis%20is%20where%20the%20economic%20argument%20comes%20in.%20Highly%20specific%20drugs%20do%20not%20repay%20the%20vast%20sums%20necessary%20to%20get%20them%20through%20clinical%20trials%20to%20prove%20their%20efficacy.%20Many%20viruses%20lay%20out%20patients%20for%20only%20a%20short%20time%20%E2%80%94%20perhaps%20a%20matter%20of%20days.%20So%20patients%20do%20not%20come%20back%20for%20repeat%20prescriptions%2C%20further%20denting%20the%20incentive%20to%20develop%20the%20drug.%20Aids%20and%20herpes%20are%20long-lasting%20exceptions%20%E2%80%94%20sexually%20transmitted%20diseases%20need%20to%20lie%20low%20inside%20your%20genes%20to%20give%20you%20time%20to%20move%20on%20to%20a%20new%20partner%20%E2%80%94%20which%20is%20why%20they%20have%20attracted%20attention%20from%20pharmaceutical%20firms.%20By%20the%20time%20some%20drugs%20were%20ready%20to%20be%20tried%20against%20ebola%20in%20the%202014-15%20epidemic%20in%20West%20Africa%2C%20it%20was%20over.%20%3C%2Fp%3E%5Cn%3Ch2%3EProtease%20inhibitors%3C%2Fh2%3E%5Cn%3Cp%3ENone%20the%20less%2C%20the%20battles%20against%20HIV%2C%20ebola%20and%20Sars%20have%20left%20us%20with%20many%20more%20candidates%20for%20curing%20Covid-19%20than%20we%20would%20otherwise%20have.%20The%20long%20search%20for%20Aids%20cures%20was%20eventually%20won%20with%20the%20help%20of%20drugs%20called%20protease%20inhibitors%2C%20which%20work%20by%20preventing%20the%20%E2%80%98cleavage%E2%80%99%20(precise%20breaking)%20of%20a%20protein%20molecule%2C%20essential%20to%20the%20manoeuvre%20by%20which%20the%20virus%20gets%20into%20a%20cell.%20%3C%2Fp%3E%5Cn%3Cp%3EProtease%20inhibitors%20tend%20to%20be%20highly%20specific%2C%20so%20the%20HIV%20ones%20are%20not%20necessarily%20useful%20against%20Sars-CoV-2.%20A%20different%20protease%20inhibitor%2C%20however%2C%20called%20camostat%20mesylate%2C%20already%20approved%20for%20use%20in%20Japan%20as%20a%20treatment%20for%20pancreatitis%2C%20is%20showing%20promise.%20It%20was%20found%20in%202012%20to%20work%20against%20Sars%20in%20the%20laboratory.%20If%20successful%2C%20camostat%20mesylate%20will%20be%20useless%20against%20most%20other%20viruses%2C%20making%20it%20unprofitable%20in%20normal%20times%2C%20but%20in%20a%20pandemic%20of%20this%20size%2C%20Japan%E2%80%99s%20Ono%20Pharmaceutical%20won%E2%80%99t%20be%20out%20of%20pocket.%3C%2Fp%3E%5Cn%3Ch2%3ERemdesivir%3C%2Fh2%3E%5Cn%3Cp%3EInvented%20by%20Gilead%20Sciences%2C%20the%20California%20firm%20that%20developed%20several%20HIV%20therapies%2C%20this%20compound%20fools%20the%20cell%20into%20using%20a%20fake%20version%20of%20a%20particular%20molecule%20when%20copying%20the%20virus%E2%80%99s%20genes%2C%20which%20are%20made%20of%20an%20alternative%20version%20of%20DNA%20called%20RNA.%20In%20theory%20such%20a%20trick%20should%20work%20against%20any%20virus%20that%20uses%20RNA%20for%20its%20genes%20and%20should%20not%20hurt%20patients%20because%20their%20genes%20are%20made%20of%20DNA.%20In%202015%20remdesivir%20worked%20against%20ebola%20in%20monkeys%2C%20but%20in%20the%202018%20epidemic%20in%20Congo%20it%20failed%20to%20make%20sufficient%20difference%20to%20ebola%20patients%20compared%20with%20other%20treatments.%20%3C%2Fp%3E%5Cn%3Cp%3EIn%20the%20lab%2C%20remdesivir%20kills%20a%20variety%20of%20coronaviruses%20and%20a%20recent%20report%20found%20that%20it%20cured%20cats%20of%20a%20coronavirus%20infection.%20During%20the%20current%20epidemic%2C%20it%20has%20been%20rushed%20into%20treatment%20on%20a%20compassionate-use%20basis%20in%20America%20for%20people%20who%20are%20dying.%20Preliminary%20results%20are%20promising%20and%20have%20caused%20a%20flurry%20of%20recent%20optimism%2C%20and%20the%20results%20of%20larger%2C%20controlled%20trials%20are%20eagerly%20awaited.%20However%2C%20remdesivir%20is%20unlikely%20to%20be%20the%20silver%20bullet%20because%20it%20is%20probably%20best%20if%20taken%20early%20in%20the%20infection%2C%20but%20you%20would%20not%20want%20to%20take%20it%20if%20you%20had%20a%20mild%20bout.%20It%E2%80%99s%20administered%20intravenously%20and%20has%20some%20nasty%20side%20effects.%3C%2Fp%3E%5Cn%3Ch2%3EFavipiravir%3C%2Fh2%3E%5Cn%3Cp%3EThere%20is%20more%20hope%20for%20favipiravir%2C%20sold%20as%20Avigan%2C%20one%20of%20the%20few%20antiviral%20treatments%20showing%20promise%20against%20more%20than%20one%20kind%20of%20virus.%20Bizarrely%2C%20it%E2%80%99s%20made%20by%20a%20subsidiary%20of%20Fujifilm%2C%20which%20diversified%20into%20chemicals%20and%20pharmaceuticals%20to%20avoid%20the%20fate%20of%20Kodak.%20Invented%20during%20the%20search%20for%20a%20herpes%20cure%2C%20it%20has%20since%20shown%20promise%20against%20influenza.%20Though%20good%20in%20the%20laboratory%2C%20it%20was%20only%20partially%20effective%20against%20ebola%20in%20Guinea%20in%202014%2C%20but%20initial%20trials%20on%2080%20coronavirus%20patients%20in%20China%20this%20year%20have%20suggested%20that%20it%20can%20speed%20up%20the%20recovery%20time%20for%20Covid%20patients%2C%20perhaps%20cutting%20it%20in%20half.%20So%20Fujifilm%20is%20now%20rushing%20to%20increase%20production%20and%20the%20drug%20has%20been%20cleared%20for%20use%20against%20coronavirus%20in%20Japan.%20The%20good%20news%20is%20it%E2%80%99s%20a%20pill%2C%20not%20an%20injection%2C%20and%20has%20few%20side%20effects%20except%20in%20pregnant%20women%2C%20where%20it%20is%20not%20safe.%3C%2Fp%3E%5Cn%3Cp%3EThe%20urgency%20surrounding%20a%20viral%20pandemic%20is%20fertile%20soil%20for%20exaggeration.%20Tamiflu%2C%20for%20influenza%2C%20is%20one%20of%20the%20world%E2%80%99s%20best-selling%20drugs%2C%20and%20governments%20spent%20billions%20acquiring%20stockpiles%20of%20it%20during%20the%202009%20swine%20flu%20panic%2C%20to%20the%20benefit%20of%20Roche%20in%20particular.%20A%20lengthy%20campaign%20by%20the%20%3Cem%3EBritish%20Medical%20Journal%3C%2Fem%3E%20has%20challenged%20the%20effectiveness%20of%20Tamiflu%2C%20pointing%20out%20that%20it%20has%20not%20been%20shown%20to%20work%20in%20randomised%20controlled%20trials.%20The%20drug%E2%80%99s%20defenders%20say%20this%20is%20unfair%2C%20as%20the%20medication%E2%80%99s%20partial%20effectiveness%20is%20so%20well%20established%20that%20it%20is%20now%20unethical%20deliberately%20to%20give%20half%20the%20patients%20in%20the%20trial%20no%20drug.%20In%20any%20case%20Tamiflu%20will%20not%20work%20against%20coronavirus%3A%20it%20targets%20an%20enzyme%20only%20used%20by%20influenza.%3C%2Fp%3E%5Cn%3Ch2%3EMonoclonal%20antibodies%3C%2Fh2%3E%5Cn%3Cp%3EIf%20chemical%20treatments%20do%20not%20work%2C%20so-called%20monoclonal%20antibodies%20might.%20If%20someone%20recovers%2C%20their%20own%20body%20produces%20antibodies%20that%20smother%20the%20virus.%20These%20days%20it%E2%80%99s%20possible%20to%20mass-produce%20exact%20copies%20of%20the%20antibodies%20that%20work%2C%20using%20genetic%20engineering.%20Known%20as%20monoclonal%20antibodies%2C%20they%20proved%20to%20be%20the%20best%20way%20to%20treat%20ebola%20patients%20in%20Congo%20in%202018%2C%20when%20the%20US%20biotech%20firm%20Regeneron%20came%20up%20with%20a%20cocktail%20of%20human%20antibodies%20using%20genetically%20engineered%20mice.%20Regeneron%20has%20rushed%20a%20new%20cocktail%20of%20Covid-19%20antibodies%20through%20the%20same%20procedure%20and%20hopes%20to%20have%20it%20ready%20to%20test%20in%20early%20summer.%20Scaling%20it%20up%20for%20mass%20production%20will%20not%2C%20however%2C%20be%20as%20easy%20as%20it%20would%20for%20a%20chemical%20pill.%20%3C%2Fp%3E%5Cn%3Ch2%3EHydroxychloroquine%20%3C%2Fh2%3E%5Cn%3Cp%3EFrench%20studies%20suggest%20that%20hydroxychloroquine%2C%20the%20malaria%20medication%20championed%20by%20Donald%20Trump%2C%20may%20well%20be%20at%20least%20a%20partial%20cure%2C%20especially%20if%20used%20in%20conjunction%20with%20the%20antibiotic%20azithromycin.%20But%20clinical%20trials%20are%20still%20awaited.%20It%20is%20not%20yet%20clear%20how%20it%20works%3A%20after%20all%2C%20malaria%20is%20neither%20a%20virus%20nor%20a%20bacterium%2C%20but%20a%20parasite.%20But%20hydroxychloroquine%20is%20used%20against%20rheumatoid%20arthritis%20and%20the%20autoimmune%20disease%20lupus.%20In%20the%20laboratory%2C%20it%20does%20seem%20to%20slow%20and%20inhibit%20the%20infection%20of%20cells%20by%20this%20coronavirus.%3C%2Fp%3E%5Cn%3Cp%3EHydroxychloroquine%20also%20tends%20to%20team%20up%20with%20the%20metal%20zinc%20and%20there%20are%20persistent%20and%20reliable%20reports%20that%20zinc%20either%20stops%20viruses%20replicating%20or%20helps%20the%20immune%20response%20to%20them.%20A%20gold-standard%20review%20of%20clinical%20trials%20found%20that%20zinc%20lozenges%20do%20shorten%20the%20duration%20of%20a%20cold%20by%20somehow%20interfering%20with%20virus%20replication.%20This%20does%20not%20just%20seem%20to%20be%20a%20diminishing-returns%20effect%20whereby%20having%20too%20little%20zinc%2C%20like%20having%20too%20little%20vitamin%20D%2C%20is%20bad%2C%20but%20once%20you%20have%20enough%2C%20having%20even%20more%20is%20no%20better.%20But%20if%20it%20is%2C%20up%20to%20a%20quarter%20of%20people%20in%20developing%20countries%20are%20deficient%20in%20zinc%2C%20and%20zinc%20deficiency%20is%20not%20uncommon%20among%20the%20elderly%20in%20western%20countries%2C%20so%20this%20may%20be%20part%20of%20the%20explanation%20why%20some%20elderly%20people%20are%20more%20seriously%20affected.%20In%20short%2C%20zinc%20supplements%20as%20a%20cheap%20medication%2C%20unrewarding%20to%20big%20pharma%20and%20therefore%20neglected%2C%20cannot%20be%20ruled%20out%20as%20a%20useful%20thing%20to%20try.%20Intriguingly%2C%20too%20much%20zinc%20kills%20your%20sense%20of%20taste%2C%20as%20does%20Covid-19%20in%20many%20cases.%3C%2Fp%3E%5Cn%3Cp%3EAltogether%2C%20I%20am%20now%20optimistic%20that%20within%20a%20month%20or%20two%2C%20one%20of%20the%2030%20or%20more%20therapies%20currently%20being%20tested%20is%20likely%20to%20prove%20effective%20and%20safe.%20Primed%20by%20Aids%20and%20ebola%2C%20we%20know%20where%20to%20look%20for%20chemicals%20that%20inhibit%20viruses%2C%20or%20prevent%20viruses%20replicating%2C%20in%20a%20way%20that%20we%20did%20not%2020%20years%20ago.%20If%20people%20can%20take%20a%20pill%20that%20drastically%20reduces%20their%20chances%20of%20dying%2C%20and%20clears%20up%20their%20symptoms%20before%20they%20need%20to%20be%20admitted%20to%20hospital%2C%20then%20we%20may%20not%20have%20to%20wait%20for%20a%20vaccine%20to%20end%20the%20lockdown%20and%20achieve%20herd%20immunity.%20%3C%2Fp%3E%22%2C%22pull_quote%22%3A%22Antibiotics%20interfere%20with%20machinery%20found%20in%20bacteria%2C%20but%20there%20is%20no%20equivalent%20machinery%20in%20viruses%22%2C%22associated_image_caption%22%3A%22%22%2C%22associated_image_alt%22%3A%22%22%2C%22addendum%22%3A%22%22%2C%22author%22%3A%7B%22uid%22%3A%22blt5207bd3193b3670e%22%2C%22type%22%3A%22author%22%2C%22title%22%3A%22Matt%20Ridley%22%2C%22url%22%3A%22%2Fwriter%2Fmatt-ridley%22%2C%22caricature_alt%22%3A%22Matt%20Ridley%22%2C%22hard_paywall%22%3Afalse%7D%2C%22topic%22%3A%5B%7B%22uid%22%3A%22blt88f8522d6cfc5bec%22%2C%22type%22%3A%22topic%22%2C%22title%22%3A%22Society%22%2C%22description%22%3A%22%22%2C%22categorisation%22%3A%22Coffee%20House%22%2C%22url%22%3A%22%2Fcategory%2Fsociety%22%2C%22meta_description%22%3A%22%22%7D%5D%2C%22related_content%22%3A%5B%5D%2C%22books_arts%22%3A%5B%5D%2C%22magazine_content_production_only%22%3A%7B%22magazine_%22%3Atrue%2C%22magazine_subsection%22%3A%22Features%22%7D%2C%22tags%22%3A%5B%5D%2C%22hard_paywall%22%3Afalse%2C%22has_magazine%22%3Atrue%2C%22magazine_title%22%3A%22The%2010%2C000th%20Issue%22%2C%22magazine_issue_date%22%3A%2225%2F04%2F2020%22%2C%22magazine_issue_description%22%3A%22%22%2C%22magazine_issue_url%22%3A%22%2Fmagazine%2F25-04-2020%22%2C%22magazine_subsection%22%3A%22Features%22%2C%22magazine_subsection_url%22%3A%22%2Fmagazines%2Ffeatures%22%2C%22magazine_page%22%3A16%2C%22comments_enabled%22%3Atrue%2C%22seo%22%3A%7B%22no_index%22%3Afalse%2C%22no_archive%22%3Afalse%2C%22no_follow%22%3Afalse%7D%2C%22image_style%22%3A%22contain%22%2C%22house_ads%22%3A%7B%22house_ad_anonymous_users%22%3A%5B%5D%2C%22house_ad_registered_users%22%3A%5B%5D%2C%22house_ad_subscribers%22%3A%5B%5D%7D%2C%22never_paywall%22%3Afalse%2C%22suppress_inline_ad%22%3Afalse%2C%22suppress_inline_house_ad%22%3Afalse%2C%22suppress_most_popular%22%3Afalse%7D%2C%22loading%22%3Afalse%2C%22loadFailed%22%3Afalse%2C%22loadFinished%22%3Atrue%2C%22initialUrl%22%3A%22%2Farticle%2Fthe-contenders-and-challenges-in-the-race-to-cure-covid%22%2C%22ssr%22%3Atrue%7D"));
  </script><div id="root"><header class="SsrSiteHeader-module__primary-header" data-analytics-id="Primary Header"><div class="SsrSiteHeader-module__primary-header__inner"><div class="SsrSiteHeader-module__primary-header__main-logo-container"><a href="/"><svg class="Logo-module__logo SsrSiteHeader-module__primary-header__main-logo" viewBox="0 0 247 56" aria-label="The Spectator"><path d="M244.413345,54.0471254 L247,54.0471254 L247,55.1555137 L237.761946,55.1555137 L236.336646,53.0442978 L225.514926,37.3157399 L222.928271,33.5155514 L222.928271,33.2516494 L225.039826,33.2516494 C232.430269,33.0405278 235.650391,30.137606 235.650391,23.5400566 C235.650391,18.5259189 232.747003,16.1508011 230.741025,15.5174364 C229.843614,15.200754 227.837637,15.0951932 226.412337,15.0951932 L222.717116,15.0951932 L222.717116,54.0471254 L227.098593,54.0471254 L227.098593,55.1555137 L212.264917,55.1555137 L212.264917,54.0471254 L216.646394,54.0471254 L216.646394,15.0951932 L212.212129,15.0951932 L212.212129,13.9868049 L228.15437,13.9868049 C232.483058,14.3034873 236.864535,14.4618285 240.084657,17.8925542 C241.519644,19.4851028 242.31005,21.5548795 242.30179,23.6983977 C242.30179,25.4929312 241.82669,28.8180961 237.973102,31.2987747 C236.17828,32.5127238 233.486047,33.4099906 229.843614,33.7794533 L244.413345,54.0471254 Z M198.48702,14.4090481 C194.158332,14.4090481 188.985022,15.8341188 188.985022,34.5183789 C188.985022,53.0442978 194.211121,54.7332705 198.48702,54.7332705 C202.762919,54.7332705 207.88344,53.3081998 207.88344,34.6239397 C207.936229,16.0980207 202.71013,14.4090481 198.48702,14.4090481 L198.48702,14.4090481 Z M198.48702,13.195099 C207.725074,13.195099 214.640417,22.1149859 214.640417,34.6239397 C214.640417,47.1328935 207.725074,55.9472196 198.48702,55.9472196 C189.143388,55.9472196 182.280834,47.0273327 182.280834,34.5183789 C182.280834,22.0094251 189.196177,13.195099 198.48702,13.195099 L198.48702,13.195099 Z M148.971051,37.2629595 L143.269852,18.9481621 L137.25192,37.2629595 L148.971051,37.2629595 Z M136.829609,38.4241282 L131.709088,54.0471254 L137.515864,54.0471254 L137.515864,55.1555137 L114.65828,55.1555137 L114.65828,54.0471254 L119.567645,54.0471254 L119.567645,15.0951932 C118.299759,15.0489847 117.030212,15.0842442 115.766846,15.200754 C113.549713,15.5174364 113.074613,17.1008483 112.75788,17.8925542 C112.28278,19.3704053 111.860469,20.795476 111.543736,22.2205467 C111.227003,23.6456173 110.85748,25.33459 110.435169,26.9180019 L109.326603,26.9180019 L109.326603,13.9868049 L136.248931,13.9868049 L136.248931,26.9180019 L135.140365,26.9180019 C134.718054,25.33459 134.454109,23.6983977 134.031798,22.2205467 C133.609487,20.9010368 133.345543,19.4231857 132.923232,17.8925542 C132.633812,16.4242353 131.405842,15.3257024 129.914266,15.200754 C128.456561,15.0902475 126.994125,15.0550138 125.532789,15.0951932 L125.532789,54.0471254 L130.336577,54.0471254 L143.481008,13.9868049 L147.387385,13.9868049 L160.215083,54.0471254 L165.335604,54.0471254 L165.335604,15.0951932 C163.87427,15.0539584 162.411779,15.0891935 160.954127,15.200754 C158.736994,15.5174364 158.261894,17.1008483 157.945161,17.8925542 C157.470061,19.3704053 157.04775,20.795476 156.731016,22.2205467 C156.414283,23.6456173 156.044761,25.33459 155.62245,26.9180019 L154.513884,26.9180019 L154.513884,13.9868049 L182.122467,13.9868049 L182.122467,26.9180019 L181.119479,26.9180019 C180.697168,25.33459 180.327646,23.6983977 179.905334,22.2205467 C179.483023,20.9010368 179.219079,19.4231857 178.796768,17.8925542 C178.507348,16.4242353 177.279378,15.3257024 175.787802,15.200754 C174.312451,15.090593 172.832459,15.0553607 171.353536,15.0951932 L171.353536,54.0471254 L176.474057,54.0471254 L176.474057,55.1555137 L148.918262,55.1555137 L148.918262,54.0471254 L154.144361,54.0471254 L149.340573,38.4241282 L136.829609,38.4241282 Z M106.687159,26.9180019 C105.895326,22.9066918 104.786759,17.8925542 102.991937,15.9924599 C101.988949,14.8840716 100.563649,14.0923657 98.0825716,14.0923657 C90.5865508,14.0923657 87.1552736,20.4787936 87.1552736,34.7295005 C87.1552736,36.9462771 87.0496959,45.5494816 89.9530842,50.4580584 C90.6411788,51.6974278 91.6422613,52.7347466 92.8564726,53.466541 C94.2463998,54.2985276 95.8294593,54.7533567 97.4491051,54.7860509 C98.6248275,54.7655181 99.7872015,54.5330807 100.880382,54.0999057 C103.36146,52.9915174 104.681182,50.66918 105.578592,47.7662582 C106.416378,45.331463 107.017432,42.82158 107.373414,40.271442 L108.481981,40.271442 L108.481981,53.3081998 C107.711194,53.7859052 106.89839,54.1922418 106.053692,54.5221489 C103.55856,55.4771383 100.912545,55.9776553 98.2409383,56 C94.3345612,56 92.0118505,54.9971725 90.7449174,54.3110273 C86.7329626,52.1998115 80.6094526,46.7106503 80.6094526,34.9934025 C80.6094526,21.5871819 88.8445178,12.8784166 98.346516,12.8784166 C101.524751,12.8797387 104.6873,13.3238456 107.742937,14.1979265 L107.742937,26.9180019 L106.687159,26.9180019 Z M78.6562641,40.2186616 L79.7648305,40.2186616 L79.7648305,55.1555137 L50.8893136,55.1555137 L50.8893136,54.0471254 L54.7956907,54.0471254 L54.7956907,15.0951932 L50.8893136,15.0951932 L50.8893136,13.9868049 L79.3425195,13.9868049 L79.3425195,26.9180019 L78.233953,26.9180019 C77.5476976,24.5956645 76.9142311,22.2205467 76.1223979,20.00377 C75.4361424,17.998115 74.9082536,17.1008483 74.327576,16.5202639 C73.3245873,15.6229972 71.8992875,15.3063148 69.2070547,15.0951932 L60.8664118,15.0951932 L60.8664118,33.0405278 L64.6672111,33.0405278 C65.9869331,32.934967 66.6731885,32.7238454 67.5705994,31.9321395 C69.048688,30.6126296 69.4709991,28.5014138 70.36841,24.9123468 L71.4769765,24.9123468 L71.4769765,42.1187559 L70.36841,42.1187559 C69.946099,40.799246 69.7877324,39.6380773 69.3654213,38.3185674 C69.1097177,37.2157754 68.6040122,36.1864689 67.8873327,35.3100848 C66.884344,34.2016965 65.7757775,34.0961357 64.1921112,34.0961357 L60.8664118,34.0961357 L60.8664118,54.0471254 L69.3654213,54.0471254 C70.4247538,54.0952921 71.4831743,53.933864 72.4799652,53.5721018 C74.9082536,52.4637135 75.9112424,49.1385485 76.5974978,47.1856739 C77.4064324,44.9013517 78.0936526,42.5757495 78.6562641,40.2186616 L78.6562641,40.2186616 Z M36.5835273,15.0951932 L34.1552389,15.0951932 L34.1552389,33.9377945 L39.0646046,33.9377945 C43.6572371,33.9377945 46.5606255,30.5070688 46.5606255,25.33459 C46.5606255,18.4203582 43.3932927,15.0951932 36.5835273,15.0951932 L36.5835273,15.0951932 Z M39.0646046,35.0461828 L34.1552389,35.0461828 L34.1552389,54.0999057 L39.1701824,54.0999057 L39.1701824,55.2082941 L24.2309296,55.2082941 L24.2309296,54.0999057 L28.1373066,54.0999057 L28.1373066,15.0951932 L25.0227628,15.0951932 L25.0227628,13.9868049 L37.2697827,13.9868049 C47.194092,13.9868049 52.7897132,17.7869934 52.7897132,24.5956645 C52.7897132,30.7181904 47.194092,35.0461828 39.0646046,35.0461828 L39.0646046,35.0461828 Z M24.2309296,48.9802074 C21.6442745,53.7832234 16.7349087,55.9472196 11.4032319,55.9472196 C7.07454381,55.9472196 4.01278881,54.7332705 0.159200629,52.8331762 L0.159200629,39.7436381 L1.26776709,39.7436381 C1.84844477,42.1715363 2.37633356,44.4410933 3.06258899,46.9745523 C3.49102078,48.7159312 4.20449582,50.3744941 5.17414416,51.8831291 C6.0715551,53.202639 8.07753252,54.7860509 11.8783318,54.7860509 C13.3564204,54.7860509 17.5795308,54.4693685 20.113397,50.5636192 C20.9743023,49.1477707 21.430735,47.5231314 21.433119,45.866164 C21.447351,44.134675 20.8907875,42.4467038 19.8494526,41.063148 C19.4071069,40.3946225 18.8741377,39.7906878 18.2657862,39.2686145 C16.0486533,37.5796418 13.4619982,36.6823751 8.55263243,34.7822809 C6.12434398,33.8850141 5.3325108,33.0933082 4.22394433,32.3543827 C2.74585571,31.4571159 0.000833991281,28.9236569 0.000833991281,24.2262017 C-0.0244178633,22.1809611 0.524225131,20.1695934 1.58450037,18.4203582 C3.59047778,14.9896324 8.60542131,12.8256362 13.4092093,12.8256362 C17.4211641,12.8256362 19.6382971,13.2478794 23.3335186,14.1451461 L23.3335186,27.2874647 L22.2249522,27.2874647 C21.3275412,23.1705938 20.4301303,18.1564562 18.6353084,16.2563619 C17.6323197,15.2535344 16.154231,14.0395853 12.8285316,14.0395853 C9.60841001,14.0395853 6.81059941,14.936852 5.01577752,17.5230914 C4.10564972,18.744249 3.60659702,20.2226861 3.59047778,21.7455231 C3.60353187,22.9594661 3.95053581,24.146394 4.59346649,25.1762488 C6.17713286,27.6569274 8.81657683,28.395853 11.5088097,29.6098021 C12.5117984,30.0320452 13.6203648,30.401508 14.5177758,30.8237512 C17.3155864,31.9321395 19.9022415,32.8294062 22.3305299,34.9406221 C23.6502519,36.0490104 25.7618071,38.529689 25.7618071,43.1743638 C25.738027,45.2062361 25.212128,47.2007048 24.2309296,48.9802074 L24.2309296,48.9802074 Z M127.591555,11.1366635 L128.700122,11.1366635 L128.700122,0.422243167 L127.591555,0.422243167 L127.591555,0 L135.615465,0 L135.615465,3.58906692 L135.193154,3.58906692 C134.190165,0.791705938 134.190165,0.369462771 133.398332,0.369462771 L130.389366,0.369462771 L130.389366,5.27803959 L131.497932,5.27803959 C132.289765,5.27803959 132.606499,5.066918 133.081599,3.27238454 L133.50391,3.27238454 L133.50391,7.70593779 L133.081599,7.70593779 C132.500921,5.91140434 132.289765,5.70028275 131.497932,5.70028275 L130.389366,5.70028275 L130.389366,11.0838831 L133.609487,11.0838831 C134.190165,11.0838831 134.401321,10.7672008 135.509887,7.38925542 L135.932198,7.38925542 L135.932198,11.5061263 L127.591555,11.5061263 L127.591555,11.1366635 Z M116.822624,11.1366635 L117.93119,11.1366635 L117.93119,0.422243167 L116.822624,0.422243167 L116.822624,0 L120.729001,0 L120.729001,0.422243167 L119.620434,0.422243167 L119.620434,5.33081998 L124.001911,5.33081998 L124.001911,0.422243167 L122.893345,0.422243167 L122.893345,0 L126.799722,0 L126.799722,0.422243167 L125.691155,0.422243167 L125.691155,11.1366635 L126.799722,11.1366635 L126.799722,11.5589067 L122.893345,11.5589067 L122.893345,11.1366635 L124.001911,11.1366635 L124.001911,5.70028275 L119.620434,5.70028275 L119.620434,11.0838831 L120.729001,11.0838831 L120.729001,11.5061263 L116.822624,11.5061263 L116.822624,11.1366635 Z M115.555691,3.58906692 C114.552702,0.580584354 114.447124,0.369462771 113.549713,0.369462771 L112.863458,0.369462771 L112.863458,11.0838831 L114.447124,11.0838831 L114.447124,11.5061263 L109.537758,11.5061263 L109.537758,11.0838831 L111.121425,11.0838831 L111.121425,0.422243167 L110.435169,0.422243167 C109.537758,0.422243167 109.432181,0.63336475 108.429192,3.64184731 L108.006881,3.64184731 L108.006881,0 L115.925213,0 L115.925213,3.58906692 L115.555691,3.58906692 Z" id="Shape"></path></svg></a></div><nav class="SsrSiteHeader-module__nav-bar" data-analytics-id="Primary Nav"><a class="NavLink2-module__nav-link" href="/coffee-house"><span class="NavLink2-module__nav-link__label">Today</span></a><a class="NavLink2-module__nav-link" href="/article/the-contenders-and-challenges-in-the-race-to-cure-covid"><span class="NavLink2-module__nav-link__label">Topics<svg width="1em" height="1em" viewBox="0 0 24 13" icon="angleDown" class="SsrSiteHeader-module__nav-link__icon SsrSiteHeader-module__nav-link__icon--after"><g id="Symbols" stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"><g id="_All-/-Icons-/-Line-/-Angle-down" transform="translate(0.000000, -6.000000)" fill="currentColor"><path d="M1.7070738,6.29286024 C1.31653129,5.90235416 0.683366313,5.90238369 0.292860237,6.2929262 C-0.0976458384,6.68346871 -0.0976163051,7.31663369 0.292926202,7.70713976 L10.774704,18.1879398 L10.7751599,18.1883957 C11.4522434,18.8654791 12.5507849,18.864763 13.2265367,18.186697 L23.7070738,7.70713976 C24.0976163,7.31663369 24.0976458,6.68346871 23.7071398,6.2929262 C23.3166337,5.90238369 22.6834687,5.90235416 22.2929262,6.29286024 L12,16.5848263 L1.7070738,6.29286024 Z" id="Icon-colour"></path></g></g></svg></span></a><a class="NavLink2-module__nav-link" href="/writers"><span class="NavLink2-module__nav-link__label">Writers<svg width="1em" height="1em" viewBox="0 0 24 13" icon="angleDown" class="SsrSiteHeader-module__nav-link__icon SsrSiteHeader-module__nav-link__icon--after"><g id="Symbols" stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"><g id="_All-/-Icons-/-Line-/-Angle-down" transform="translate(0.000000, -6.000000)" fill="currentColor"><path d="M1.7070738,6.29286024 C1.31653129,5.90235416 0.683366313,5.90238369 0.292860237,6.2929262 C-0.0976458384,6.68346871 -0.0976163051,7.31663369 0.292926202,7.70713976 L10.774704,18.1879398 L10.7751599,18.1883957 C11.4522434,18.8654791 12.5507849,18.864763 13.2265367,18.186697 L23.7070738,7.70713976 C24.0976163,7.31663369 24.0976458,6.68346871 23.7071398,6.2929262 C23.3166337,5.90238369 22.6834687,5.90235416 22.2929262,6.29286024 L12,16.5848263 L1.7070738,6.29286024 Z" id="Icon-colour"></path></g></g></svg></span></a><a class="NavLink2-module__nav-link" href="/podcasts"><span class="NavLink2-module__nav-link__label">Podcasts</span></a><a class="NavLink2-module__nav-link" href="/magazine"><span class="NavLink2-module__nav-link__label">Magazine<svg width="1em" height="1em" viewBox="0 0 24 13" icon="angleDown" class="SsrSiteHeader-module__nav-link__icon SsrSiteHeader-module__nav-link__icon--after"><g id="Symbols" stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"><g id="_All-/-Icons-/-Line-/-Angle-down" transform="translate(0.000000, -6.000000)" fill="currentColor"><path d="M1.7070738,6.29286024 C1.31653129,5.90235416 0.683366313,5.90238369 0.292860237,6.2929262 C-0.0976458384,6.68346871 -0.0976163051,7.31663369 0.292926202,7.70713976 L10.774704,18.1879398 L10.7751599,18.1883957 C11.4522434,18.8654791 12.5507849,18.864763 13.2265367,18.186697 L23.7070738,7.70713976 C24.0976163,7.31663369 24.0976458,6.68346871 23.7071398,6.2929262 C23.3166337,5.90238369 22.6834687,5.90235416 22.2929262,6.29286024 L12,16.5848263 L1.7070738,6.29286024 Z" id="Icon-colour"></path></g></g></svg></span></a><a class="NavLink2-module__nav-link" href="/article/the-contenders-and-challenges-in-the-race-to-cure-covid"><span class="NavLink2-module__nav-link__label">More<svg width="1em" height="1em" viewBox="0 0 24 13" icon="angleDown" class="SsrSiteHeader-module__nav-link__icon SsrSiteHeader-module__nav-link__icon--after"><g id="Symbols" stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"><g id="_All-/-Icons-/-Line-/-Angle-down" transform="translate(0.000000, -6.000000)" fill="currentColor"><path d="M1.7070738,6.29286024 C1.31653129,5.90235416 0.683366313,5.90238369 0.292860237,6.2929262 C-0.0976458384,6.68346871 -0.0976163051,7.31663369 0.292926202,7.70713976 L10.774704,18.1879398 L10.7751599,18.1883957 C11.4522434,18.8654791 12.5507849,18.864763 13.2265367,18.186697 L23.7070738,7.70713976 C24.0976163,7.31663369 24.0976458,6.68346871 23.7071398,6.2929262 C23.3166337,5.90238369 22.6834687,5.90235416 22.2929262,6.29286024 L12,16.5848263 L1.7070738,6.29286024 Z" id="Icon-colour"></path></g></g></svg></span></a><a class="NavLink2-module__nav-link NavLink2-module__nav-link--has-icon-before" href="/article/the-contenders-and-challenges-in-the-race-to-cure-covid"><svg width="1em" height="1em" viewBox="0 0 24 24" icon="search" class="NavLink2-module__nav-link__icon NavLink2-module__nav-link__icon--before"><defs><filter x="-8.3%" y="-8.3%" width="116.7%" height="116.7%" filterUnits="objectBoundingBox" id="search_svg__b"><feOffset dx="4" dy="2" in="SourceAlpha" result="shadowOffsetInner1"></feOffset><feComposite in="shadowOffsetInner1" in2="SourceAlpha" operator="arithmetic" k2="-1" k3="1" result="shadowInnerInner1"></feComposite><feColorMatrix values="0 0 0 0 1 0 0 0 0 1 0 0 0 0 1 0 0 0 1 0" in="shadowInnerInner1"></feColorMatrix></filter><path d="M167.835 190.574l-6.047-6.047a.556.556 0 00-.398-.164h-.483a9.707 9.707 0 002.592-6.613 9.748 9.748 0 00-9.75-9.75 9.748 9.748 0 00-9.749 9.75 9.748 9.748 0 0016.363 7.162v.478c0 .15.061.29.164.398l6.047 6.047c.22.22.576.22.797 0l.464-.464a.563.563 0 000-.797z" id="search_svg__a"></path></defs><g transform="translate(-144 -168)" fill="none" fill-rule="evenodd"><use fill-opacity="0.05" fill="currentColor" xlink:href="#search_svg__a"></use><use fill="#000" filter="url(#search_svg__b)" xlink:href="#search_svg__a"></use><path stroke="currentColor" d="M160.258 184.329l.282-.305a9.205 9.205 0 002.459-6.274c0-5.11-4.14-9.25-9.25-9.25-5.109 0-9.249 4.14-9.249 9.25a9.248 9.248 0 0015.524 6.794l.234-.215zm.605.534v.527a.07.07 0 00.018.045l6.046 6.046a.063.063 0 00.09 0l.464-.464a.063.063 0 000-.09l-6.046-6.046a.057.057 0 00-.045-.018h-.527z" stroke-linejoin="square"></path></g></svg><span class="NavLink2-module__nav-link__label NavLink2-module__nav-link__label--has-icon-before">Search</span></a><a class="NavLink2-module__nav-link NavLink2-module__nav-link--has-icon-before" href="/account"><svg width="1em" height="1em" viewBox="0 0 24 24" icon="user" class="NavLink2-module__nav-link__icon NavLink2-module__nav-link__icon--before"><defs><filter x="-8.3%" y="-8.3%" width="116.7%" height="116.7%" filterUnits="objectBoundingBox" id="user_svg__b"><feOffset dx="4" dy="2" in="SourceAlpha" result="shadowOffsetInner1"></feOffset><feComposite in="shadowOffsetInner1" in2="SourceAlpha" operator="arithmetic" k2="-1" k3="1" result="shadowInnerInner1"></feComposite><feColorMatrix values="0 0 0 0 1 0 0 0 0 1 0 0 0 0 1 0 0 0 1 0" in="shadowInnerInner1"></feColorMatrix></filter><path d="M92 181.5a6.752 6.752 0 006.75-6.75A6.752 6.752 0 0092 168a6.752 6.752 0 00-6.75 6.75A6.752 6.752 0 0092 181.5zm6 1.5h-2.583a8.169 8.169 0 01-6.834 0H86a6 6 0 00-6 6v.75a2.25 2.25 0 002.25 2.25h19.5a2.25 2.25 0 002.25-2.25V189a6 6 0 00-6-6z" id="user_svg__a"></path></defs><g transform="translate(-80 -168)" fill="none" fill-rule="evenodd"><use fill-opacity="0.05" fill="currentColor" xlink:href="#user_svg__a"></use><use fill="currentColor" filter="url(#user_svg__b)" xlink:href="#user_svg__a"></use><path stroke="currentColor" d="M92 181c3.45 0 6.25-2.8 6.25-6.25s-2.8-6.25-6.25-6.25-6.25 2.8-6.25 6.25S88.55 181 92 181zm3.525 2.5a8.663 8.663 0 01-7.05 0H86a5.5 5.5 0 00-5.5 5.5v.75c0 .966.784 1.75 1.75 1.75h19.5a1.75 1.75 0 001.75-1.75V189a5.5 5.5 0 00-5.5-5.5h-2.475z" stroke-linejoin="square"></path></g></svg><span class="NavLink2-module__nav-link__label NavLink2-module__nav-link__label--has-icon-before">Account</span></a></nav></div></header><section id="content" data-content-uid="blt2bed63306951402f"><header><div class="ContentPageBreadcrumbs-module__mobile" data-analytics-id="Content Page - Meta - Breadcrumb"><div class="ContentPageBreadcrumbs-module__breadcrumbs--outer"><div class="ContentPageBreadcrumbs-module__breadcrumbs--inner"><a class="ContentPageBreadcrumbs-module__link ContentPageBreadcrumbs-module__link--political ContentPageBreadcrumbs-module__mobile-back__link" href="/magazine/25-04-2020"><svg width="1em" height="1em" viewBox="0 0 13 24" icon="angleLeft" class="ContentPageBreadcrumbs-module__mobile-back__icon"><path d="M2.061 12L12.39 1.672A.98.98 0 1011.004.287L.5 10.789c-.669.67-.668 1.756.002 2.424l10.5 10.5a.98.98 0 101.386-1.385L2.06 12z" fill="currentColor" fill-rule="evenodd"></path></svg>Magazine<!-- -->: <!-- -->25 April 2020</a></div></div></div><div class="ContentPageBreadcrumbs-module__not-mobile" data-analytics-id="Content Page - Meta - Breadcrumb"><div class="ContentPageBreadcrumbs-module__breadcrumbs--outer"><div class="ContentPageBreadcrumbs-module__breadcrumbs--inner" itemscope="" itemType="https://schema.org/BreadcrumbList"><a class="ContentPageBreadcrumbs-module__link ContentPageBreadcrumbs-module__link--political ContentPageBreadcrumbs-module__home" href="/"><meta itemProp="position" content="1"/><meta itemProp="name" content="Home"/><span itemProp="item" itemscope="" itemID="/"><svg width="1em" height="1em" viewBox="0 0 24 24" icon="home"><path d="M23.708 11.294l-11-11a1 1 0 00-1.414 0l-11 11A1 1 0 001 13h1.25a.25.25 0 01.25.25V23a1 1 0 001 1h5.75a.25.25 0 00.25-.25v-4.75a2.5 2.5 0 115 0v4.75c0 .138.112.25.25.25h5.75a1 1 0 001-1v-9.75a.25.25 0 01.25-.25h1.25a1 1 0 00.707-1.707z" fill="currentColor" fill-rule="nonzero"></path></svg></span></a><svg width="1em" height="1em" viewBox="0 0 13 24" icon="angleRight" class="ContentPageBreadcrumbs-module__divider"><path d="M10.586 12L.293 22.293a1 1 0 001.414 1.414L12.19 13.224a1.732 1.732 0 00-.002-2.45L1.708.292A1 1 0 00.292 1.707L10.586 12z" fill="currentColor" fill-rule="evenodd"></path></svg><a class="ContentPageBreadcrumbs-module__link ContentPageBreadcrumbs-module__link--political" href="/magazine"><meta itemProp="position" content="2"/><meta itemProp="name" content="Magazine"/><span itemProp="item" itemscope="" itemID="/magazine">Magazine</span></a><svg width="1em" height="1em" viewBox="0 0 13 24" icon="angleRight" class="ContentPageBreadcrumbs-module__divider"><path d="M10.586 12L.293 22.293a1 1 0 001.414 1.414L12.19 13.224a1.732 1.732 0 00-.002-2.45L1.708.292A1 1 0 00.292 1.707L10.586 12z" fill="currentColor" fill-rule="evenodd"></path></svg><a class="ContentPageBreadcrumbs-module__link ContentPageBreadcrumbs-module__link--political" href="/magazine/25-04-2020"><meta itemProp="position" content="3"/><meta itemProp="name" content="Issue: 25 April 2020"/><span itemProp="item" itemscope="" itemID="/magazine/25-04-2020">Issue: 25 April 2020</span></a><svg width="1em" height="1em" viewBox="0 0 13 24" icon="angleRight" class="ContentPageBreadcrumbs-module__divider"><path d="M10.586 12L.293 22.293a1 1 0 001.414 1.414L12.19 13.224a1.732 1.732 0 00-.002-2.45L1.708.292A1 1 0 00.292 1.707L10.586 12z" fill="currentColor" fill-rule="evenodd"></path></svg><a class="ContentPageBreadcrumbs-module__link ContentPageBreadcrumbs-module__link--political" href="/magazines/features"><meta itemProp="position" content="4"/><meta itemProp="name" content="Features"/><span itemProp="item" itemscope="" itemID="/magazines/features">Features</span></a></div></div></div><div class="ContentPageHeader-module__main" data-analytics-id="Content Page - Header"><a class="Hyperlink2-module__link--political ContentPageAuthor-module__author" href="/writer/matt-ridley"><h2 class="ContentPageAuthor-module__author__name">Matt Ridley</h2></a><div class="ContentPageHeader-module__titles"><h1 class="ContentPageTitle-module__headline">The contenders – and challenges – in the race to<!-- --> <span class="ContentPageTitle-module__prevent-widows">cure Covid</span></h1><h3 class="ContentPageStandfirst-module__standfirst">There are reasons to be optimistic about the therapies<!-- --> <span class="ContentPageStandfirst-module__prevent-widows">being tested</span></h3></div></div><div class="ContentPageMetadata-module__container--outer"><div class="ContentPageMetadata-module__container--inner"><div class="ContentPageMetadataItem-module__item"><svg width="1em" height="1em" viewBox="0 0 24 22" icon="magazine" class="ContentPageMetadataItem-module__icon"><path d="M11.977 21.749h.007l-.025-.002.058.001.025-.001-.013.001h.005L12 21.75l-.023-.001zm-.055-.004l.037.002h-.007l.025.002h-.015l-.015-.002h-.01l-.015-.002zm.237-.014l-.05.011h-.005l-.009.002-.013.001-.005.001-.021.001-.008.002-.014-.001.016-.001h-.008l.027-.002.046-.006.044-.008zm-.304.003l.035.006.05.006-.035-.002-.004-.001h-.003l-.016-.003-.014-.003h.003l-.016-.003zm-.01-.002l.023.005-.02-.002-.011-.004h-.009l-.009-.004h-.005l-.005-.002-.008-.002-.043-.014-.022-.007-.008-.003-.005-.002-.009-.004.032.012.02.006.006.002.053.015.02.004zm.326-.003l-.014.005-.021.002.035-.007zm.128-.042l-.054.02.029-.008-.01.003-.029.008-.023.01-.013.002-.009.004-.002-.001-.001.002-.016.002.003-.001-.015.003.023-.005.034-.01.083-.029zm.063-.033l-.029.016.022-.01-.007.005-.018.007-.02.011-.01.005.012-.008-.024.011.029-.013.045-.024zm.037-.021l-.009.006.008-.004-.006.005-.011.004-.017.012-.009.004.022-.013-.015.007.02-.01.017-.011zm-.764.021l.087.042-.041-.019.033.016-.006-.002-.033-.016-.023-.01-.008-.006-.022-.011-.03-.02-.02-.012-.025-.019.052.035.036.022zm.814-.056l-.024.018.008-.005-.005.005-.014.008-.01.009-.006.002.012-.009-.011.007.016-.011.034-.024zm.032-.024l-.002.004-.014.008-.019.017-.013.008.026-.021-.01.008.032-.024zm.047-.045l-.028.028.011-.009-.009.01-.009.006-.005.006-.007.004.004-.004-.01.008.014-.012.039-.037zm.044-.043l-.023.023.014-.014a.75.75 0 00.009-.009zm.062-.084l-.02.028a.752.752 0 00.02-.028zm.053-.1a.744.744 0 01-.008.017zm-1.41-.102l-.02-.091v-.013c.004.035.01.07.02.104zm.002.008l-.002-.008.03.084-.018-.046c.009.028.02.055.032.081l.016.028c.002.009.01.023.019.037l-.015-.029.018.034c.014.024.03.047.047.07l.007.007-.019-.026.041.051.018.02.011.011.036.035.019.017.028.023-.02-.015-.015-.014-.014-.01-.015-.016-.013-.011-.015-.017-.036-.036a2.965 2.965 0 00-.293-.24l-.096-.07c-.424-.3-.98-.605-1.685-.894-1.966-.807-4.633-1.314-8.116-1.361A1.264 1.264 0 010 17.644V1.27A1.27 1.27 0 011.278 0C4.926.05 7.776.591 9.92 1.473c.927.382 1.61.773 2.08 1.121.47-.348 1.154-.74 2.08-1.12C16.225.59 19.074.048 22.721 0c.342-.005.67.13.907.37.24.239.372.562.372.9v16.369a1.268 1.268 0 01-1.24 1.274c-3.471.047-6.139.554-8.105 1.36-.704.29-1.261.596-1.685.896a2.94 2.94 0 00-.413.333l-.01.009-.026.029-.01.008.025-.026-.008.007.011-.011.033-.033a.747.747 0 00.165-.345l.005-.038.007-.062.001-.053a.747.747 0 00-.193-.489 3.771 3.771 0 00-.556-.49 3.672 3.672 0 00-.558.49.747.747 0 00-.193.493l.003.048L11.25 21c0 .072.01.142.03.208zM1.5 1.504v15.913c3.54.07 6.314.607 8.414 1.47.52.213.964.43 1.336.64V3.918a5.078 5.078 0 00-.22-.164c-.422-.3-.978-.605-1.68-.894-1.917-.789-4.502-1.29-7.85-1.357zm21 0c-3.348.066-5.932.568-7.85 1.357-.702.289-1.258.594-1.68.894a5.08 5.08 0 00-.22.164v15.607c.372-.21.816-.426 1.336-.64 2.102-.863 4.88-1.4 8.414-1.469z" fill="currentColor" fill-rule="evenodd"></path></svg>From magazine issue<!-- -->:<!-- --> <a class="Hyperlink2-module__link--political" href="/magazine/25-04-2020">25 April 2020</a></div></div></div></header><figure class="ContentPageHero-module__container"><div class="ContentPageHeroImage-module__media__container"><div class="ResponsiveImage2-module__image-container ResponsiveImage2-module__absolute"><picture class="ResponsiveImage2-module__image-inner"><source srcSet="https://images.contentstack.io/v3/assets/bltf04078f3cf7a9c30/blt98c910a52989f814/5e9ed458c492412a1bbc190e/chemical-weapons.jpg?auto=webp&amp;format=jpg&amp;width=50&amp;height=50&amp;fit=bounds"/><img alt="The contenders – and challenges – in the race to cure Covid" class="ResponsiveImage2-module__placeholder-image ResponsiveImage2-module__absolute"/></picture></div></div></figure><section class="ContentPageTools-module__tools"><div class="ContentPageTextSettings-module__container"><span class="ContentPageToolsButton-module__button__outer ContentPageToolsButton-module__button--with-divider ContentPageToolsButton-module__button--hover"><span class="ContentPageToolsButton-module__button__inner"><svg width="1em" height="1em" viewBox="0 0 24 21" icon="text" class="ContentPageToolsButton-module__icon ContentPageToolsButton-module__icon--political"><path d="M17.552 18.93h-.606a.243.243 0 01-.23-.166L10.646.989A1.461 1.461 0 009.269 0h-.007c-.626 0-1.183.399-1.385.991l-6.05 17.773a.245.245 0 01-.23.165h-.587a.977.977 0 100 1.954h2.94a.976.976 0 00.977-.975v-.002a.947.947 0 00-.81-.95.245.245 0 01-.185-.317l1.497-4.402a.245.245 0 01.232-.166h7.21c.105 0 .198.067.232.166l1.503 4.403a.246.246 0 01-.154.311l-.026.007a.95.95 0 00-.791.949.976.976 0 00.975.977H17.551a.977.977 0 100-1.954h.001zM6.493 12.115a.245.245 0 01-.23-.323L9.03 3.66a.244.244 0 01.463 0l2.776 8.132a.243.243 0 01-.232.321l-5.545.003zm16.498 6.813h-.22a.245.245 0 01-.23-.165L18.294 6.339a1.526 1.526 0 00-2.892 0l-1.146 3.376a.977.977 0 101.85.63l.514-1.51a.244.244 0 01.462 0l1.462 4.29a.244.244 0 01-.23.323h-1.358a.977.977 0 000 1.954h2.194c.105 0 .198.066.232.165l1.097 3.204a.243.243 0 01-.117.299.952.952 0 00-.519.846.976.976 0 00.976.977h2.171a.977.977 0 100-1.954v-.01z" fill="currentColor" fill-rule="nonzero"></path></svg><span class="ContentPageToolsButton-module__label">Text<span class="ContentPageTextSettings-module__long-label"> settings</span></span></span></span></div><span class="ContentPageToolsButton-module__button__outer ContentPageToolsButton-module__button--with-divider ContentPageToolsButton-module__button--hover ContentPageCommentsLink-module__button"><span class="ContentPageToolsButton-module__button__inner"><svg width="1em" height="1em" viewBox="0 0 24 24" icon="comments" class="ContentPageToolsButton-module__icon ContentPageToolsButton-module__icon--grey"><path d="M4.518 19.482H2.212A2.212 2.212 0 010 17.271V2.21C0 .992.99 0 2.212 0h19.576C23.01 0 24 .99 24 2.212V17.27c0 1.22-.99 2.211-2.212 2.211H11.482L5.647 23.86a.706.706 0 01-1.13-.565v-3.812zm1.411 2.4l4.895-3.67a.706.706 0 01.423-.141h10.541a.8.8 0 00.8-.8V2.21a.8.8 0 00-.8-.8H2.212a.8.8 0 00-.8.8v15.06a.8.8 0 00.8.8h3.012c.39 0 .705.316.705.705v3.106z" fill="currentColor" fill-rule="evenodd" fill-opacity=".4"></path></svg><span class="ContentPageToolsButton-module__label">Comments</span></span></span><span class="ContentPageTools-module__share-label">Share</span><div class="ContentPageShare-module__container__outer"><div class="ContentPageShare-module__container__inner"><a href="http://api.addthis.com/oexchange/0.8/forward/facebook/offer?url=https://www.spectator.co.uk/article/the-contenders-and-challenges-in-the-race-to-cure-covid&amp;pubid=ra-5d9f5a457676f6b2&amp;title=The contenders – and challenges – in the race to cure Covid&amp;screenshot=https://images.contentstack.io/v3/assets/bltf04078f3cf7a9c30/blt98c910a52989f814/5e9ed458c492412a1bbc190e/chemical-weapons.jpg" class="ContentPageSocialShareButton-module__social-channel ContentPageShare-module__share-button"><button tabindex="0" class="Button2-module__button Button2-module__htmlButtonReset Button2-module__htmlButtonReset--block Button2-module__primary-stylized Button2-module__button--size-s Button2-module__button--block Button2-module__button--size-s--normal Button2-module__button--circle Button2-module__button--circle--size-s ContentPageShare-module__share-button"><span class="Button2-module__button__container--outer"><span class="Button2-module__button__container--inner"><svg width="1em" height="1em" viewBox="0 0 13 24" icon="facebook" class="undefined Button2-module__icon--size-xxl Button2-module__icon--only"><path d="M12.375 3.984V.17C11.985.117 10.645 0 9.085 0c-3.258 0-5.49 1.988-5.49 5.64V9H0v4.266h3.595V24h4.407V13.266h3.45L12 9H8.002V6.06c0-1.232.342-2.076 2.114-2.076h2.259z" fill="currentColor" fill-rule="nonzero"></path></svg></span></span></button></a><a href="http://api.addthis.com/oexchange/0.8/forward/twitter/offer?url=https://www.spectator.co.uk/article/the-contenders-and-challenges-in-the-race-to-cure-covid&amp;pubid=ra-5d9f5a457676f6b2&amp;title=The contenders – and challenges – in the race to cure Covid&amp;screenshot=https://images.contentstack.io/v3/assets/bltf04078f3cf7a9c30/blt98c910a52989f814/5e9ed458c492412a1bbc190e/chemical-weapons.jpg&amp;via=spectator" class="ContentPageSocialShareButton-module__social-channel ContentPageShare-module__share-button"><button tabindex="0" class="Button2-module__button Button2-module__htmlButtonReset Button2-module__htmlButtonReset--block Button2-module__primary-stylized Button2-module__button--size-s Button2-module__button--block Button2-module__button--size-s--normal Button2-module__button--circle Button2-module__button--circle--size-s ContentPageShare-module__share-button"><span class="Button2-module__button__container--outer"><span class="Button2-module__button__container--inner"><svg width="1em" height="1em" viewBox="0 0 30 24" icon="twitter" class="undefined Button2-module__icon--size-xxl Button2-module__icon--only"><path d="M26.513 5.981c.018.263.018.525.018.788C26.531 14.775 20.438 24 9.3 24c-3.431 0-6.619-.994-9.3-2.719.488.056.956.075 1.462.075 2.832 0 5.438-.956 7.52-2.587a6.067 6.067 0 01-5.663-4.2c.375.056.75.093 1.144.093.543 0 1.087-.075 1.593-.206A6.057 6.057 0 011.2 8.512v-.074a6.1 6.1 0 002.737.768 6.052 6.052 0 01-2.7-5.044c0-1.125.3-2.156.825-3.056A17.215 17.215 0 0014.55 7.444a6.837 6.837 0 01-.15-1.388C14.4 2.72 17.1 0 20.456 0c1.744 0 3.319.731 4.425 1.912A11.924 11.924 0 0028.725.45a6.04 6.04 0 01-2.663 3.337c1.22-.13 2.4-.468 3.488-.937a13.019 13.019 0 01-3.037 3.131z" fill="currentColor" fill-rule="nonzero"></path></svg></span></span></button></a><a href="http://api.addthis.com/oexchange/0.8/forward/whatsapp/offer?url=https://www.spectator.co.uk/article/the-contenders-and-challenges-in-the-race-to-cure-covid&amp;pubid=ra-5d9f5a457676f6b2&amp;title=The contenders – and challenges – in the race to cure Covid&amp;screenshot=https://images.contentstack.io/v3/assets/bltf04078f3cf7a9c30/blt98c910a52989f814/5e9ed458c492412a1bbc190e/chemical-weapons.jpg" class="ContentPageSocialShareButton-module__social-channel ContentPageShare-module__share-button"><button tabindex="0" class="Button2-module__button Button2-module__htmlButtonReset Button2-module__htmlButtonReset--block Button2-module__primary-stylized Button2-module__button--size-s Button2-module__button--block Button2-module__button--size-s--normal Button2-module__button--circle Button2-module__button--circle--size-s ContentPageShare-module__share-button"><span class="Button2-module__button__container--outer"><span class="Button2-module__button__container--inner"><svg width="1em" height="1em" viewBox="0 0 24 24" icon="whatsapp" class="undefined Button2-module__icon--size-xxl Button2-module__icon--only"><path d="M12 0C5.408 0 .049 5.356 0 11.996a11.882 11.882 0 002.14 6.819L.79 22.843a.507.507 0 00.63.645l4.2-1.34c5.613 3.55 13.02 1.844 16.544-3.81A12.146 12.146 0 0024 11.996C23.951 5.356 18.592 0 12 0zm7.2 16.84a3.905 3.905 0 01-3.5 2.105 10.668 10.668 0 01-3.45-1.007 14.031 14.031 0 01-5.95-5.197c-1.91-2.548-2-4.935-.16-6.91A2.16 2.16 0 018 5.269c.526.063.983.393 1.21.876l.38.927.63 1.52c.16.317.16.691 0 1.008a5.166 5.166 0 01-1 1.38 12.48 12.48 0 001.79 2.165 9.046 9.046 0 002.73 1.642c.28-.363.83-1.007 1-1.28a.996.996 0 011.34-.362c.38.141 2.51 1.188 2.51 1.188.271.093.507.264.68.494a2.027 2.027 0 01-.07 2.014z" fill="currentColor" fill-rule="nonzero"></path></svg></span></span></button></a><div class="ContentPageShare-module__tooltip-container"><button class="Button2-module__button Button2-module__htmlButtonReset Button2-module__htmlButtonReset--block Button2-module__primary-stylized Button2-module__button--size-s Button2-module__button--block Button2-module__button--size-s--normal Button2-module__button--circle Button2-module__button--circle--size-s"><span class="Button2-module__button__container--outer"><span class="Button2-module__button__container--inner"><svg width="1em" height="1em" viewBox="0 0 89 24" icon="ellipsis" class="undefined Button2-module__icon--size-xxl Button2-module__icon--only"><path d="M12 0c6.628 0 12 5.372 12 12s-5.372 12-12 12S0 18.628 0 12 5.372 0 12 0zm32.308 0c6.627 0 12 5.372 12 12s-5.373 12-12 12c-6.628 0-12-5.372-12-12s5.372-12 12-12zm32.307 0c6.628 0 12 5.372 12 12s-5.372 12-12 12c-6.627 0-12-5.372-12-12s5.373-12 12-12z" fill="currentColor" fill-rule="nonzero"></path></svg></span></span></button></div></div></div></section><main class="ContentPageBody-module__body__container"><div class="ContentPageBody-module__body__content"><p class="ContentPageBodyParagraph-module__paragraph--block ContentPageBodyParagraph-module__paragraph--size-medium--spacing-normal">A striking feature of Covid-19 is how medieval our response has had to be. Quarantine was the way people fought plagues in the distant past. We know by now that it will take many months to get a vaccine, whose job is to prevent you getting the disease. But what about a cure once you have caught it: why is there no pill to take? The truth is that, advanced as medical science is, we are mostly defenceless against viruses. There is no antiviral therapy to compare with antibiotics for treating bacteria.</p><p class="ContentPageBodyParagraph-module__paragraph--block ContentPageBodyParagraph-module__paragraph--size-medium--spacing-normal">Arguably, virology in 2020 is where bacteriology was in the 1920s. At the time, most of the experts in that field — including Alexander Fleming and his mentor, the formidable Sir Almroth Wright (nicknamed Sir Always Wrong by his foes) — thought a chemical therapy that killed bacteria without harming the patient was a wild goose chase. Instead, they argued, theway to fight bacteria was to encourage the body’s immune system. ‘Stimulate the phagocytes!’ was the cry of Wright’s semi-fictional avatar Sir Colenso Ridgeon in George Bernard Shaw’s play <em class="ContentPageBodyEm-module__em">The Doctor’s Dilemma</em> (referring to white blood cells). Vaccines should be used to treat as well as prevent infections, thought Wright and Fleming. Fleming then turned this theory upside down with his discovery of penicillin in 1928.</p><p class="ContentPageBodyParagraph-module__paragraph--block ContentPageBodyParagraph-module__paragraph--size-medium--spacing-normal">There are two reasons for this failure to have anything on the shelf that can be used to treat viruses: one biological, the other economic. The biological problem, as Amesh Adalja of Johns Hopkins University argued in a prescient call to arms just before the pandemic struck, is that viruses do not have their own biochemistry, because they borrow ours.</p><p class="ContentPageBodyParagraph-module__paragraph--block ContentPageBodyParagraph-module__paragraph--size-medium--spacing-normal">So unlike, say, tuberculosis, there is not much to attack. As any doctor will tell you, antibiotics are no use in fighting a virus. They interfere with machinery found only in bacteria, but there is no equivalent machinery in viruses — which are just a bunch of genes (15 of them in the case of Sars-CoV-2) that borrow our body’s machinery to replicate themselves.</p><p class="ContentPageBodyParagraph-module__paragraph--block ContentPageBodyParagraph-module__paragraph--size-medium--spacing-normal">The problem is that viruses differ from each other, so treatments that work for one seldom work for another. The drugs that work against HIV-1, the main cause of Aids, sometimes do not even work against HIV-2,a milder version of the virus. Those that work against herpes don’t kill the very similar cytomegalovirus. One influenza drug works only against influenza A and not B. One antiviral kills just one genotype of hepatitis C. It is no coincidence that the antiviral treatments capable of attacking more kinds of virus, such as ribavirin, are also the most toxic to the patient, because they tend to attack the machinery of the host as well.</p><p class="ContentPageBodyParagraph-module__paragraph--block ContentPageBodyParagraph-module__paragraph--size-medium--spacing-normal">This is where the economic argument comes in. Highly specific drugs do not repay the vast sums necessary to get them through clinical trials to prove their efficacy. Many viruses lay out patients for only a short time — perhaps a matter of days. So patients do not come back for repeat prescriptions, further denting the incentive to develop the drug. Aids and herpes are long-lasting exceptions — sexually transmitted diseases need to lie low inside your genes to give you time to move on to a new partner — which is why they have attracted attention from pharmaceutical firms. By the time some drugs were ready to be tried against ebola in the 2014-15 epidemic in West Africa, it was over. </p><h2 class="ContentPageBodyHeading-module__heading ContentPageBodyHeading-module__h2">Protease inhibitors</h2><p class="ContentPageBodyParagraph-module__paragraph--block ContentPageBodyParagraph-module__paragraph--size-medium--spacing-normal">None the less, the battles against HIV, ebola and Sars have left us with many more candidates for curing Covid-19 than we would otherwise have. The long search for Aids cures was eventually won with the help of drugs called protease inhibitors, which work by preventing the ‘cleavage’ (precise breaking) of a protein molecule, essential to the manoeuvre by which the virus gets into a cell. </p><p class="ContentPageBodyParagraph-module__paragraph--block ContentPageBodyParagraph-module__paragraph--size-medium--spacing-normal">Protease inhibitors tend to be highly specific, so the HIV ones are not necessarily useful against Sars-CoV-2. A different protease inhibitor, however, called camostat mesylate, already approved for use in Japan as a treatment for pancreatitis, is showing promise. It was found in 2012 to work against Sars in the laboratory. If successful, camostat mesylate will be useless against most other viruses, making it unprofitable in normal times, but in a pandemic of this size, Japan’s Ono Pharmaceutical won’t be out of pocket.</p><h2 class="ContentPageBodyHeading-module__heading ContentPageBodyHeading-module__h2">Remdesivir</h2><p class="ContentPageBodyParagraph-module__paragraph--block ContentPageBodyParagraph-module__paragraph--size-medium--spacing-normal">Invented by Gilead Sciences, the California firm that developed several HIV therapies, this compound fools the cell into using a fake version of a particular molecule when copying the virus’s genes, which are made of an alternative version of DNA called RNA. In theory such a trick should work against any virus that uses RNA for its genes and should not hurt patients because their genes are made of DNA. In 2015 remdesivir worked against ebola in monkeys, but in the 2018 epidemic in Congo it failed to make sufficient difference to ebola patients compared with other treatments. </p><p class="ContentPageBodyParagraph-module__paragraph--block ContentPageBodyParagraph-module__paragraph--size-medium--spacing-normal">In the lab, remdesivir kills a variety of coronaviruses and a recent report found that it cured cats of a coronavirus infection. During the current epidemic, it has been rushed into treatment on a compassionate-use basis in America for people who are dying. Preliminary results are promising and have caused a flurry of recent optimism, and the results of larger, controlled trials are eagerly awaited. However, remdesivir is unlikely to be the silver bullet because it is probably best if taken early in the infection, but you would not want to take it if you had a mild bout. It’s administered intravenously and has some nasty side effects.</p><h2 class="ContentPageBodyHeading-module__heading ContentPageBodyHeading-module__h2">Favipiravir</h2><p class="ContentPageBodyParagraph-module__paragraph--block ContentPageBodyParagraph-module__paragraph--size-medium--spacing-normal">There is more hope for favipiravir, sold as Avigan, one of the few antiviral treatments showing promise against more than one kind of virus. Bizarrely, it’s made by a subsidiary of Fujifilm, which diversified into chemicals and pharmaceuticals to avoid the fate of Kodak. Invented during the search for a herpes cure, it has since shown promise against influenza. Though good in the laboratory, it was only partially effective against ebola in Guinea in 2014, but initial trials on 80 coronavirus patients in China this year have suggested that it can speed up the recovery time for Covid patients, perhaps cutting it in half. So Fujifilm is now rushing to increase production and the drug has been cleared for use against coronavirus in Japan. The good news is it’s a pill, not an injection, and has few side effects except in pregnant women, where it is not safe.</p><p class="ContentPageBodyParagraph-module__paragraph--block ContentPageBodyParagraph-module__paragraph--size-medium--spacing-normal">The urgency surrounding a viral pandemic is fertile soil for exaggeration. Tamiflu, for influenza, is one of the world’s best-selling drugs, and governments spent billions acquiring stockpiles of it during the 2009 swine flu panic, to the benefit of Roche in particular. A lengthy campaign by the <em class="ContentPageBodyEm-module__em">British Medical Journal</em> has challenged the effectiveness of Tamiflu, pointing out that it has not been shown to work in randomised controlled trials. The drug’s defenders say this is unfair, as the medication’s partial effectiveness is so well established that it is now unethical deliberately to give half the patients in the trial no drug. In any case Tamiflu will not work against coronavirus: it targets an enzyme only used by influenza.</p><h2 class="ContentPageBodyHeading-module__heading ContentPageBodyHeading-module__h2">Monoclonal antibodies</h2><p class="ContentPageBodyParagraph-module__paragraph--block ContentPageBodyParagraph-module__paragraph--size-medium--spacing-normal">If chemical treatments do not work, so-called monoclonal antibodies might. If someone recovers, their own body produces antibodies that smother the virus. These days it’s possible to mass-produce exact copies of the antibodies that work, using genetic engineering. Known as monoclonal antibodies, they proved to be the best way to treat ebola patients in Congo in 2018, when the US biotech firm Regeneron came up with a cocktail of human antibodies using genetically engineered mice. Regeneron has rushed a new cocktail of Covid-19 antibodies through the same procedure and hopes to have it ready to test in early summer. Scaling it up for mass production will not, however, be as easy as it would for a chemical pill. </p><h2 class="ContentPageBodyHeading-module__heading ContentPageBodyHeading-module__h2">Hydroxychloroquine </h2><p class="ContentPageBodyParagraph-module__paragraph--block ContentPageBodyParagraph-module__paragraph--size-medium--spacing-normal">French studies suggest that hydroxychloroquine, the malaria medication championed by Donald Trump, may well be at least a partial cure, especially if used in conjunction with the antibiotic azithromycin. But clinical trials are still awaited. It is not yet clear how it works: after all, malaria is neither a virus nor a bacterium, but a parasite. But hydroxychloroquine is used against rheumatoid arthritis and the autoimmune disease lupus. In the laboratory, it does seem to slow and inhibit the infection of cells by this coronavirus.</p><div class="ContentPageBodyHouseAd-module__container"></div><p class="ContentPageBodyParagraph-module__paragraph--block ContentPageBodyParagraph-module__paragraph--size-medium--spacing-normal">Hydroxychloroquine also tends to team up with the metal zinc and there are persistent and reliable reports that zinc either stops viruses replicating or helps the immune response to them. A gold-standard review of clinical trials found that zinc lozenges do shorten the duration of a cold by somehow interfering with virus replication. This does not just seem to be a diminishing-returns effect whereby having too little zinc, like having too little vitamin D, is bad, but once you have enough, having even more is no better. But if it is, up to a quarter of people in developing countries are deficient in zinc, and zinc deficiency is not uncommon among the elderly in western countries, so this may be part of the explanation why some elderly people are more seriously affected. In short, zinc supplements as a cheap medication, unrewarding to big pharma and therefore neglected, cannot be ruled out as a useful thing to try. Intriguingly, too much zinc kills your sense of taste, as does Covid-19 in many cases.</p><p class="ContentPageBodyParagraph-module__paragraph--block ContentPageBodyParagraph-module__paragraph--size-medium--spacing-normal">Altogether, I am now optimistic that within a month or two, one of the 30 or more therapies currently being tested is likely to prove effective and safe. Primed by Aids and ebola, we know where to look for chemicals that inhibit viruses, or prevent viruses replicating, in a way that we did not 20 years ago. If people can take a pill that drastically reduces their chances of dying, and clears up their symptoms before they need to be admitted to hospital, then we may not have to wait for a vaccine to end the lockdown and achieve herd immunity. </p><div class="ContentPageBody-module__measure"><aside class="MidrollPullQuote-module__container__outer"><span class="MidrollPullQuote-module__container__inner MidrollPullQuote-module__container__inner--political">Antibiotics interfere with machinery found in bacteria, but there is no equivalent machinery in viruses</span></aside></div></div></main><footer class="ContentPageFooter-module__footer"><div class="ContentPageFooterAuthor-module__author"><a class="Hyperlink2-module__link--political" href="/writer/matt-ridley"></a><div><span class="ContentPageFooterAuthor-module__label">Written by</span><a class="Hyperlink2-module__link--political ContentPageFooterAuthor-module__author__name" href="/writer/matt-ridley">Matt Ridley</a></div></div><div class="ContentPageFooterTools-module__tools"><span class="ContentPageToolsButton-module__button__outer ContentPageToolsButton-module__button--with-divider ContentPageToolsButton-module__button--hover ContentPageCommentsLink-module__button Responsive-module__responsive Responsive-module__tablet--block Responsive-module__laptop--block Responsive-module__desktop--block"><span class="ContentPageToolsButton-module__button__inner"><svg width="1em" height="1em" viewBox="0 0 24 24" icon="comments" class="ContentPageToolsButton-module__icon ContentPageToolsButton-module__icon--grey"><path d="M4.518 19.482H2.212A2.212 2.212 0 010 17.271V2.21C0 .992.99 0 2.212 0h19.576C23.01 0 24 .99 24 2.212V17.27c0 1.22-.99 2.211-2.212 2.211H11.482L5.647 23.86a.706.706 0 01-1.13-.565v-3.812zm1.411 2.4l4.895-3.67a.706.706 0 01.423-.141h10.541a.8.8 0 00.8-.8V2.21a.8.8 0 00-.8-.8H2.212a.8.8 0 00-.8.8v15.06a.8.8 0 00.8.8h3.012c.39 0 .705.316.705.705v3.106z" fill="currentColor" fill-rule="evenodd" fill-opacity=".4"></path></svg><span class="ContentPageToolsButton-module__label">Comments</span></span></span><span class="ContentPageFooterTools-module__share-label">Share</span><div class="ContentPageShare-module__container__outer ContentPageFooterTools-module__footer-share"><div class="ContentPageShare-module__container__inner"><a href="http://api.addthis.com/oexchange/0.8/forward/facebook/offer?url=https://www.spectator.co.uk/article/the-contenders-and-challenges-in-the-race-to-cure-covid&amp;pubid=ra-5d9f5a457676f6b2&amp;title=The contenders – and challenges – in the race to cure Covid&amp;screenshot=https://images.contentstack.io/v3/assets/bltf04078f3cf7a9c30/blt98c910a52989f814/5e9ed458c492412a1bbc190e/chemical-weapons.jpg" class="ContentPageSocialShareButton-module__social-channel ContentPageShare-module__share-button"><button tabindex="0" class="Button2-module__button Button2-module__htmlButtonReset Button2-module__htmlButtonReset--block Button2-module__primary-stylized Button2-module__button--size-s Button2-module__button--block Button2-module__button--size-s--normal Button2-module__button--circle Button2-module__button--circle--size-s ContentPageShare-module__share-button"><span class="Button2-module__button__container--outer"><span class="Button2-module__button__container--inner"><svg width="1em" height="1em" viewBox="0 0 13 24" icon="facebook" class="undefined Button2-module__icon--size-xxl Button2-module__icon--only"><path d="M12.375 3.984V.17C11.985.117 10.645 0 9.085 0c-3.258 0-5.49 1.988-5.49 5.64V9H0v4.266h3.595V24h4.407V13.266h3.45L12 9H8.002V6.06c0-1.232.342-2.076 2.114-2.076h2.259z" fill="currentColor" fill-rule="nonzero"></path></svg></span></span></button></a><a href="http://api.addthis.com/oexchange/0.8/forward/twitter/offer?url=https://www.spectator.co.uk/article/the-contenders-and-challenges-in-the-race-to-cure-covid&amp;pubid=ra-5d9f5a457676f6b2&amp;title=The contenders – and challenges – in the race to cure Covid&amp;screenshot=https://images.contentstack.io/v3/assets/bltf04078f3cf7a9c30/blt98c910a52989f814/5e9ed458c492412a1bbc190e/chemical-weapons.jpg&amp;via=spectator" class="ContentPageSocialShareButton-module__social-channel ContentPageShare-module__share-button"><button tabindex="0" class="Button2-module__button Button2-module__htmlButtonReset Button2-module__htmlButtonReset--block Button2-module__primary-stylized Button2-module__button--size-s Button2-module__button--block Button2-module__button--size-s--normal Button2-module__button--circle Button2-module__button--circle--size-s ContentPageShare-module__share-button"><span class="Button2-module__button__container--outer"><span class="Button2-module__button__container--inner"><svg width="1em" height="1em" viewBox="0 0 30 24" icon="twitter" class="undefined Button2-module__icon--size-xxl Button2-module__icon--only"><path d="M26.513 5.981c.018.263.018.525.018.788C26.531 14.775 20.438 24 9.3 24c-3.431 0-6.619-.994-9.3-2.719.488.056.956.075 1.462.075 2.832 0 5.438-.956 7.52-2.587a6.067 6.067 0 01-5.663-4.2c.375.056.75.093 1.144.093.543 0 1.087-.075 1.593-.206A6.057 6.057 0 011.2 8.512v-.074a6.1 6.1 0 002.737.768 6.052 6.052 0 01-2.7-5.044c0-1.125.3-2.156.825-3.056A17.215 17.215 0 0014.55 7.444a6.837 6.837 0 01-.15-1.388C14.4 2.72 17.1 0 20.456 0c1.744 0 3.319.731 4.425 1.912A11.924 11.924 0 0028.725.45a6.04 6.04 0 01-2.663 3.337c1.22-.13 2.4-.468 3.488-.937a13.019 13.019 0 01-3.037 3.131z" fill="currentColor" fill-rule="nonzero"></path></svg></span></span></button></a><a href="http://api.addthis.com/oexchange/0.8/forward/whatsapp/offer?url=https://www.spectator.co.uk/article/the-contenders-and-challenges-in-the-race-to-cure-covid&amp;pubid=ra-5d9f5a457676f6b2&amp;title=The contenders – and challenges – in the race to cure Covid&amp;screenshot=https://images.contentstack.io/v3/assets/bltf04078f3cf7a9c30/blt98c910a52989f814/5e9ed458c492412a1bbc190e/chemical-weapons.jpg" class="ContentPageSocialShareButton-module__social-channel ContentPageShare-module__share-button"><button tabindex="0" class="Button2-module__button Button2-module__htmlButtonReset Button2-module__htmlButtonReset--block Button2-module__primary-stylized Button2-module__button--size-s Button2-module__button--block Button2-module__button--size-s--normal Button2-module__button--circle Button2-module__button--circle--size-s ContentPageShare-module__share-button"><span class="Button2-module__button__container--outer"><span class="Button2-module__button__container--inner"><svg width="1em" height="1em" viewBox="0 0 24 24" icon="whatsapp" class="undefined Button2-module__icon--size-xxl Button2-module__icon--only"><path d="M12 0C5.408 0 .049 5.356 0 11.996a11.882 11.882 0 002.14 6.819L.79 22.843a.507.507 0 00.63.645l4.2-1.34c5.613 3.55 13.02 1.844 16.544-3.81A12.146 12.146 0 0024 11.996C23.951 5.356 18.592 0 12 0zm7.2 16.84a3.905 3.905 0 01-3.5 2.105 10.668 10.668 0 01-3.45-1.007 14.031 14.031 0 01-5.95-5.197c-1.91-2.548-2-4.935-.16-6.91A2.16 2.16 0 018 5.269c.526.063.983.393 1.21.876l.38.927.63 1.52c.16.317.16.691 0 1.008a5.166 5.166 0 01-1 1.38 12.48 12.48 0 001.79 2.165 9.046 9.046 0 002.73 1.642c.28-.363.83-1.007 1-1.28a.996.996 0 011.34-.362c.38.141 2.51 1.188 2.51 1.188.271.093.507.264.68.494a2.027 2.027 0 01-.07 2.014z" fill="currentColor" fill-rule="nonzero"></path></svg></span></span></button></a><div class="ContentPageShare-module__tooltip-container"><button class="Button2-module__button Button2-module__htmlButtonReset Button2-module__htmlButtonReset--block Button2-module__primary-stylized Button2-module__button--size-s Button2-module__button--block Button2-module__button--size-s--normal Button2-module__button--circle Button2-module__button--circle--size-s"><span class="Button2-module__button__container--outer"><span class="Button2-module__button__container--inner"><svg width="1em" height="1em" viewBox="0 0 89 24" icon="ellipsis" class="undefined Button2-module__icon--size-xxl Button2-module__icon--only"><path d="M12 0c6.628 0 12 5.372 12 12s-5.372 12-12 12S0 18.628 0 12 5.372 0 12 0zm32.308 0c6.627 0 12 5.372 12 12s-5.373 12-12 12c-6.628 0-12-5.372-12-12s5.372-12 12-12zm32.307 0c6.628 0 12 5.372 12 12s-5.372 12-12 12c-6.627 0-12-5.372-12-12s5.373-12 12-12z" fill="currentColor" fill-rule="nonzero"></path></svg></span></span></button></div></div></div></div><div class="ContentPageTags-module__container"><span class="ContentPageTags-module__heading">Topics<span class="ContentPageTags-module__heading--extra"> in this article</span></span><span><a class="Hyperlink2-module__link--political ContentPageTags-module__link ContentPageTags-module__topic" href="/category/society">Society</a></span></div></footer></section><div class="Footer10kEdition-module__background"><img src="https://spectator-piano-assets.s3.eu-west-2.amazonaws.com/img/10k-edition/10k-edition-footer-desktop.jpg" srcSet="
          https://spectator-piano-assets.s3.eu-west-2.amazonaws.com/img/10k-edition/10k-edition-footer-tablet.jpg 700w,
          https://spectator-piano-assets.s3.eu-west-2.amazonaws.com/img/10k-edition/10k-edition-footer-desktop.jpg 1400w" sizes="
          (min-width: 880px) 1400px,
          700px" class="Footer10kEdition-module__mural"/><a href="https://spectator.co.uk/10k" class="Footer10kEdition-module__content"><img src="https://spectator-piano-assets.s3.eu-west-2.amazonaws.com/img/10k-edition/10k-edition-logo-white-64px-2.jpg" class="Footer10kEdition-module__ten-k-logo"/><p class="Footer10kEdition-module__description">Choose your favourite <i>Spectator</i> cover and and you could<!-- --> <strong>win a signed illustration from Michael Heath</strong></p><p class="Footer10kEdition-module__cta">Browse the covers<svg width="1em" height="1em" viewBox="0 0 13 24" icon="angleRight" class="Footer10kEdition-module__cta__icon"><path d="M10.586 12L.293 22.293a1 1 0 001.414 1.414L12.19 13.224a1.732 1.732 0 00-.002-2.45L1.708.292A1 1 0 00.292 1.707L10.586 12z" fill="currentColor" fill-rule="evenodd"></path></svg></p></a></div><div class="spectator-footer-expando"></div><div class="spectator-footer spectator-container"><div class="spectator-grid spectator-laptop-hidden spectator-desktop-hidden"><div class="spectator-container-full spectator-col-sm-11 spectator-offset-sm-1"><div class="spectator-grid"><div class="spectator-footer__link-section spectator-col-xs-24 spectator-footer__first-link-section"><div class="spectator-footer__heading">Commercial</div><ul class="spectator-footer__link-list plain-list"><a href="/advertising" class="spectator-footer__link">Advertise with us</a><a href="https://events.spectator.co.uk/sponsorship-pages/client-events" class="spectator-footer__link">Sponsor an event</a></ul></div><div class="spectator-footer__link-section spectator-col-xs-24 spectator-footer__second-link-section"><div class="spectator-footer__heading">More from The Spectator</div><ul class="spectator-footer__link-list plain-list"><a href="https://life.spectator.co.uk" class="spectator-footer__link">Spectator Life</a><a href="https://spectator.us" class="spectator-footer__link">Spectator USA</a><a href="https://www.spectator.com.au" class="spectator-footer__link">Spectator Australia</a><a href="https://www.apollo-magazine.com" class="spectator-footer__link">Apollo Magazine</a><a href="https://shop.spectator.co.uk" class="spectator-footer__link">The Spectator Shop</a></ul></div></div></div><div class="spectator-container-full spectator-offset-sm-1 spectator-col-sm-11"><div class="spectator-grid"><div class="spectator-footer__link-section spectator-col-xs-24 spectator-footer__third-link-section"><div class="spectator-footer__heading">About us</div><ul class="spectator-footer__link-list plain-list"><a href="/about" class="spectator-footer__link"><span>About <span class="spectator-font-oblique">The Spectator</span></span></a><a href="/faqs" class="spectator-footer__link">Contact &amp; FAQs</a><a href="/privacy-policy" class="spectator-footer__link">Privacy &amp; cookies</a><a href="/terms" class="spectator-footer__link">Terms and conditions</a><a href="/vacancies" class="spectator-footer__link">Jobs and vacancies</a><a href="/sitemap" class="spectator-footer__link">Site map</a></ul></div><div class="spectator-footer__link-section spectator-col-xs-24 spectator-footer__last-link-section"><div class="spectator-footer__heading">Subscribe</div><ul class="spectator-footer__link-list plain-list"><a href="https://subscribe.spectator.co.uk/beta?tpcc=A511A" class="spectator-footer__link">Subscribe today</a><a href="/emails" class="spectator-footer__link">Sign up to our emails</a><a href="/spectator-club" class="spectator-footer__link">The Spectator Club</a></ul></div></div></div></div><div class="spectator-grid spectator-mobile-hidden spectator-tablet-hidden"><div class="spectator-col-1"></div><div class="spectator-footer__link-section spectator-col-4 spectator-footer__first-link-section"><div class="spectator-footer__heading">Commercial</div><ul class="spectator-footer__link-list plain-list"><a href="/advertising" class="spectator-footer__link">Advertise with us</a><a href="https://events.spectator.co.uk/sponsorship-pages/client-events" class="spectator-footer__link">Sponsor an event</a></ul></div><div class="spectator-footer__link-section-spacer spectator-col-2"></div><div class="spectator-footer__link-section spectator-col-4 spectator-footer__second-link-section"><div class="spectator-footer__heading">About us</div><ul class="spectator-footer__link-list plain-list"><a href="/about" class="spectator-footer__link"><span>About <span class="spectator-font-oblique">The Spectator</span></span></a><a href="/faqs" class="spectator-footer__link">Contact &amp; FAQs</a><a href="/privacy-policy" class="spectator-footer__link">Privacy &amp; cookies</a><a href="/terms" class="spectator-footer__link">Terms and conditions</a><a href="/vacancies" class="spectator-footer__link">Jobs and vacancies</a><a href="/sitemap" class="spectator-footer__link">Site map</a></ul></div><div class="spectator-footer__link-section-spacer spectator-col-2"></div><div class="spectator-footer__link-section spectator-col-4 spectator-footer__third-link-section"><div class="spectator-footer__heading">More from The Spectator</div><ul class="spectator-footer__link-list plain-list"><a href="https://life.spectator.co.uk" class="spectator-footer__link">Spectator Life</a><a href="https://spectator.us" class="spectator-footer__link">Spectator USA</a><a href="https://www.spectator.com.au" class="spectator-footer__link">Spectator Australia</a><a href="https://www.apollo-magazine.com" class="spectator-footer__link">Apollo Magazine</a><a href="https://shop.spectator.co.uk" class="spectator-footer__link">The Spectator Shop</a></ul></div><div class="spectator-footer__link-section-spacer spectator-col-2"></div><div class="spectator-footer__link-section spectator-col-4 spectator-footer__last-link-section"><div class="spectator-footer__heading">Subscribe</div><ul class="spectator-footer__link-list plain-list"><a class="spectator-footer__link" href="https://subscribe.spectator.co.uk/beta?tpcc=A511A">Subscribe today</a><a class="spectator-footer__link" href="/emails">Sign up to our emails</a><a class="spectator-footer__link" href="/spectator-club">The Spectator Club</a></ul></div><div class="spectator-col-1"></div></div></div><div class="uncontrolled-content-footer-banner"></div></div>
    <div id="footer-banner"></div>
    <div id="account-view"></div>
    <div id="account-physical-subscriptions"></div>
    <script src="https://code.jquery.com/jquery-3.4.1.slim.min.js" type="text/javascript"></script>
    <a href="/hidden_article" rel="nofollow" style="display: none" aria-hidden="true">Hidden Article</a>
    
    <script src="/main.js"></script>
    
  </body>
</html